This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_HYPOPHARYNX_EXALLC for full statistics.
Malignant neoplasm of hypopharynx
C3_HYPOPHARYNX
hypopharynx cancer: A primary or metastatic malignant neoplasm that affects the hypopharynx.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
134 |
4. Check minimum number of eventsNone |
134 |
5. Include endpoints |
134 |
6. Filter based on genotype QC (FinnGen only) |
134 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of hypopharynx
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 134 | 15 | 119 |
| Unadjusted period prevalence (%) | 0.05 | 0.01 | 0.05 |
| Median age at first event (years) | 68.99 | 68.20 | 69.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 126
- Matched controls
- 1259
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UJC01
NOMESCO Finland
Scopy of lower throat
620.3
96.3
84
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
209.2
86.0
82
11
JDB10
NOMESCO Finland
Percutaneous gastrostomy
189.9
85.1
82
12
8070/3-C13.9
ICD-O-3
Squamous cell carcinoma, NOS, of hypopharynx, NOS
+∞
79.9
68
*
C13.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of hypopharynx
+∞
65.4
57
*
130
Kela drug reimbursment
Malignant tumour
31.8
59.2
89
88
C13.9
ICD-10 Finland
Malignant neoplasm: Hypopharynx, unspecified
+∞
48.0
43
*
WF002
NOMESCO Finland
Radical radiotherapy
19.4
36.8
60
56
GBB00
NOMESCO Finland
Tracheostomy
81.2
28.5
31
5
A03FA01
ATC
metoclopramide; systemic, rectal
8.9
26.1
69
151
UJC02
NOMESCO Finland
Rigid oesophagoscopy
113.5
25.8
27
*
R4190
NOMESCO Finland
Nutritional therapy
27.9
25.7
35
17
D10.7
ICD-10 Finland
Benign neoplasm: Hypopharynx
+∞
24.8
23
*
C12
ICD-10 Finland
Malignant neoplasm of piriform sinus
+∞
23.7
22
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
14.1
23.5
42
43
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
56.6
23.5
27
6
C13.1
ICD-10 Finland
Malignant neoplasm: Aryepiglottic fold, hypopharyngeal aspect
278.6
23.5
23
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
24.4
23.3
33
18
N02AA05
ATC
oxycodone; systemic
7.7
22.8
65
152
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
97.5
22.6
24
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
263.9
22.4
22
*
C13.2
ICD-10 Finland
Malignant neoplasm: Posterior wall of hypopharynx
+∞
21.5
20
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
16.1
19.5
32
26
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
83.1
19.4
21
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
221.6
19.1
19
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
20.8
18.9
28
17
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
32.5
18.6
24
9
C13.0
ICD-10 Finland
Malignant neoplasm: Postcricoid region
+∞
18.2
17
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
208.0
18.0
18
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
12.0
17.6
33
36
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
9.3
17.2
38
56
UDQ22
NOMESCO Finland
Microlaryngoscopy
104.2
17.0
18
*
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
44.2
15.9
19
5
UDH02
NOMESCO Finland
Rhinopharyngoscopy
9.5
14.2
30
40
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
84.2
13.9
15
*
8070/3-C12.9
ICD-O-3
Squamous cell carcinoma, NOS, of pyriform sinus
+∞
13.8
13
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
156.1
13.7
14
*
H02AB02
ATC
dexamethasone; systemic
6.6
13.5
37
74
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
32.4
13.4
17
6
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.4
13.2
64
240
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
9.8
13.2
27
34
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.4
12.9
29
43
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
+∞
12.7
12
*
8070/3-C13.2
ICD-O-3
Squamous cell carcinoma, NOS, of posterior wall of hypopharynx
+∞
12.7
12
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.2
12.4
62
237
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
13.7
12.4
21
18
EBA15
NOMESCO Finland
Extraction of large number of teeth
9.1
12.2
26
35
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.9
12.0
70
303
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
12.3
11.8
21
20
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
11.6
11
*
R07.0
ICD-10 Finland
Pain in throat
14.7
11.6
19
15
WZC30
NOMESCO Finland
Teaching
5.3
11.5
38
94
ZX095
NOMESCO Finland
Combined chemoradiotherapy
22.6
11.5
16
8
XX3DW
NOMESCO Finland
Time consuming IT work
5.8
11.4
34
75
TJD20
NOMESCO Finland
Change of gastrostomy tube
47.9
11.1
13
*
R13
ICD-10 Finland
Dysphagia
7.0
11.1
28
49
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.7
11.0
21
23
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
6.2
11.0
31
63
ZX090
NOMESCO Finland
Other technic of radiotherapy
12.2
10.7
19
18
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
119.5
10.6
11
*
ENA10
NOMESCO Finland
Biopsy of pharynx
119.5
10.6
11
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
119.5
10.6
11
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
10.6
10
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
43.9
10.2
12
*
UJC12
NOMESCO Finland
Flexible oesophagoscopy
43.9
10.2
12
*
UDQ02
NOMESCO Finland
Direct laryngoscopy
43.9
10.2
12
*
WX402
NOMESCO Finland
General anaesthesia
4.8
10.1
36
96
WX002
NOMESCO Finland
Sedation and analgesia
4.0
9.9
46
159
GD1AD
NOMESCO Finland
Thorax CT examination
7.6
9.8
23
36
DQA10
NOMESCO Finland
Biopsy of larynx
59.7
9.8
11
*
A06AD11
ATC
lactulose; oral
4.3
9.6
39
118
TGB20
NOMESCO Finland
Tracheostomy tube replacement
107.8
9.6
10
*
Z51.5
ICD-10 Finland
Palliative care
6.2
9.2
25
48
Z2446
NOMESCO Finland
Social worker
8.3
9.2
20
28
ZXB10
NOMESCO Finland
Medial
39.8
9.2
11
*
A02BC05
ATC
esomeprazole; systemic
3.3
8.9
62
289
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
53.8
8.8
10
*
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
21.9
8.6
12
6
EBA10
NOMESCO Finland
Surgical removal of tooth
5.5
8.6
26
57
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
29.8
8.6
11
*
A07AA02
ATC
nystatin; oral
7.8
8.5
19
28
8070/3-C13.1
ICD-O-3
Squamous cell carcinoma, NOS, of hypopharyngeal aspect of aryepiglottic fold
+∞
8.4
8
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
+∞
8.4
8
*
ENB30
NOMESCO Finland
Laryngopharyngectomy
+∞
8.4
8
*
ZXE00
NOMESCO Finland
One hour or less
3.1
8.4
69
357
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.5
8.3
19
29
A04AA01
ATC
ondansetron; systemic, rectal
5.9
8.2
23
46
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
23.9
8.2
11
5
K02.1
ICD-10 Finland
Caries of dentine
2.9
7.9
73
401
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
8.6
7.7
16
21
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
17.0
7.4
11
7
JDB00
NOMESCO Finland
Gastrostomy
+∞
7.4
7
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
7.4
7
*
DQB30
NOMESCO Finland
Laryngectomy
+∞
7.4
7
*
GBB13
NOMESCO Finland
Revision of tracheostomy
+∞
7.4
7
*
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
21.5
7.3
10
5
N06AX11
ATC
mirtazapine; oral
3.0
7.1
49
218
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
6.6
51
240
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.0
6.6
27
81
A04AA02
ATC
granisetron; systemic, transdermal
5.4
6.6
19
40
A04AD12
ATC
aprepitant; systemic
15.4
6.5
10
7
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.8
6.5
21
50
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
73.4
6.5
7
*
RD210
NOMESCO Finland
NA
11.9
6.4
11
10
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
+∞
6.3
6
*
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
+∞
6.3
6
*
N05CF01
ATC
zopiclone; oral
2.7
6.2
55
283
WW500
NOMESCO Finland
Blood transfusion
6.4
6.1
15
26
ZZA00
NOMESCO Finland
Split skin graft
6.4
6.1
15
26
SAA03
NOMESCO Finland
Extended examination of mouth
2.7
6.0
50
245
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
52
98
8.04
29.11
1.6
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
22
14.42
26.41
1.5
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
74
368
3.26
10.35
3.4
2.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
55
252
3.01
8.53
10.2
6.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
58
278
2.92
8.23
3.2
2.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
34
126
3.28
7.47
2.0
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
90
583
2.66
6.59
13.4
10.2
e9/l
4.9
4.3
1.25
79
502
(40768804) Tissue Pathology biopsy report
67
382
2.51
6.37
3.4
2.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
64
364
2.45
6.04
6.1
4.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
9
11.88
5.90
1.2
1.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
74
459
2.37
5.63
5.2
6.5
%
2.5
2.7
0.21
66
425
(3019069) Monocytes/100 leukocytes in Blood
74
461
2.35
5.55
5.2
6.7
%
9.7
9.0
0.76
67
431
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
77
495
2.31
5.28
4.5
4.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
73
460
2.29
5.24
5.0
6.3
%
64.2
58.6
2.36
66
430
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
47
743
0.43
5.00
3.5
5.1
ug/l
2.1
2.9
0.69
42
662
(3022096) Basophils/100 leukocytes in Blood
71
449
2.24
4.97
5.3
6.5
%
0.7
0.6
0.20
65
417
(3002030) Lymphocytes/100 leukocytes in Blood
73
468
2.23
4.93
5.5
6.7
%
19.7
25.5
3.97
66
434
(3018418) pH of Serum or Plasma
55
323
2.19
4.53
5.5
4.2
ph
7.4
7.4
0.71
11
64
(3032080) INR in Blood by Coagulation assay
74
495
2.11
4.29
9.1
9.9
inr
1.2
1.3
0.36
19
133
(3006315) Basophils [#/volume] in Blood
74
498
2.09
4.19
5.4
6.3
e9/l
0.0
0.0
0.87
59
427
(3021589) Normoblasts [#/volume] in Blood
70
463
2.07
4.14
9.9
11.3
e9/l
0.0
0.0
0.10
55
379
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
77
989
0.48
4.07
3.1
4.8
mmol/l
4.2
4.3
0.44
70
902
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
20
77
2.88
4.02
1.8
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
74
505
2.04
3.96
5.3
6.4
e9/l
1.4
1.9
2.94
62
440
(3001604) Monocytes [#/volume] in Blood
73
497
2.03
3.92
5.4
6.2
e9/l
0.6
0.6
0.05
58
425
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
77
984
0.49
3.88
3.0
4.8
mmol/l
1.4
1.3
0.34
69
887
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
36
189
2.24
3.82
2.2
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
34
177
2.23
3.67
29.1
27.1
inr
1.7
1.3
—
6
18
(3013115) Eosinophils [#/volume] in Blood
74
515
1.98
3.65
5.9
6.5
e9/l
0.1
0.2
2.68
60
445
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
22
97
2.52
3.42
1.4
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
133
2.29
3.30
2.2
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
135
2.25
3.19
1.9
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
83
1015
0.52
3.16
3.5
5.5
mmol/l
2.4
2.5
0.89
72
917
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
75
543
1.87
3.11
8.9
7.5
mmol/l
1.2
1.2
0.21
63
464
(1761868) Lipid panel - Serum or Plasma
16
336
0.41
3.01
2.7
3.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
78
965
0.54
2.94
4.2
6.5
mmol/mol
39.2
41.0
0.82
69
889
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
78
963
0.55
2.88
2.9
4.3
mmol/l
1.2
1.3
1.19
71
864
(42870588) Differential panel, method unspecified - Blood
53
352
1.84
2.84
5.5
6.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
47
301
1.86
2.82
3.0
3.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
9
24
3.94
2.72
1.6
1.3
mmol/l
48.1
61.7
—
9
24
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
41
593
0.56
2.50
3.8
4.6
%
22.3
21.9
0.04
18
299
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
150
0.31
2.33
12.6
8.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
47
323
1.70
2.14
3.0
3.2
e6/l
0.2
0.4
1.55
40
240
(3045788) Cell count panel - Pleural fluid
5
10
5.14
2.09
1.6
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
21
113
2.02
2.06
2.0
4.8
mmol/l
4.0
1.8
0.55
15
84
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
84
987
0.60
2.05
4.2
5.1
mmol/l
6.0
6.2
1.01
76
884
(3026782) Osmolality of Urine
37
242
1.73
2.00
2.4
3.1
mosm/kgh2o
528.1
576.2
0.65
31
206
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
21
3.46
1.99
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
21
3.46
1.99
1.3
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
39
2.69
1.97
6.0
3.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
11
4.67
1.96
1.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
11
4.67
1.96
9.0
2.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
29
179
1.79
1.90
1.7
1.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
76
2.10
1.72
1.5
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
25
382
0.58
1.70
3.1
4.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
129
1.84
1.69
5.3
3.4
—
—
—
0
0
(3012544) pH of Venous blood
20
115
1.87
1.63
2.0
4.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
14
3.67
1.63
1.2
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
49
363
1.55
1.59
2.9
3.3
e6/l
33.0
253.3
0.68
42
284
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
189
1.68
1.57
2.5
2.9
e6/l
0.9
1.0
0.06
15
111
(3012441) Differential panel - Pleural fluid
5
15
3.42
1.53
1.6
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
15
3.42
1.53
9.8
3.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
37
500
0.64
1.48
2.6
3.8
estimate
0.0
0.0
—
10
84
(3000991) Gas panel - Venous blood
18
104
1.84
1.46
7.1
9.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
74
2.00
1.45
1.9
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
16
3.20
1.45
2.6
2.1
e9/l
2.2
5.0
—
5
16
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
54
417
1.49
1.42
2.9
3.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
96
1067
0.65
1.39
39.6
20.5
umol/l
76.5
88.8
4.26
96
1067
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
17
3.01
1.37
2.6
3.2
%
56.4
62.1
—
5
17
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
29
197
1.60
1.34
2.5
2.6
e6/l
0.5
0.8
0.73
15
117
(3039443) Prostate specific Ag panel - Serum or Plasma
0
41
0.00
1.33
0.0
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
37
491
0.66
1.33
2.6
3.7
estimate
0.0
0.0
—
10
90
(3018095) Leukocytes [#/volume] in Urine
51
398
1.45
1.25
3.2
3.8
e6/l
131.1
83.4
0.23
42
300
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
31
422
0.65
1.24
2.3
3.1
ug/l
0.7
0.9
1.01
20
291
(1616796) Gas panel - Central venous blood
6
26
2.37
1.20
3.3
3.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
0
34
0.00
1.17
0.0
1.5
—
0.1
—
0
10
(3021601) Nitrite [Presence] in Urine by Test strip
38
492
0.68
1.17
3.4
5.0
estimate
0.0
0.0
—
10
91
(3003694) ABO and Rh group [Type] in Blood
34
249
1.49
1.13
1.2
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
101
1099
0.67
1.11
45.1
24.5
e12/l
4.1
4.5
8.80
95
1059
(3010813) Leukocytes [#/volume] in Blood
101
1099
0.67
1.11
45.3
24.6
e9/l
7.3
6.8
1.69
95
1059
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
41
2.01
1.11
2.3
2.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
101
1098
0.67
1.09
45.2
24.5
e9/l
255.9
231.4
1.78
96
1061
(3021447) Carbon dioxide [Partial pressure] in Venous blood
18
115
1.65
1.06
2.2
4.8
kpa
6.1
5.6
1.03
18
107
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
22
2.32
1.04
1.2
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
22
2.32
1.04
1.2
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
22
2.32
1.04
1.0
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
22
2.32
1.04
1.0
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
22
2.32
1.04
1.2
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
35
2.05
1.01
1.1
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
35
2.05
1.01
1.1
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
19
274
0.64
0.98
3.4
4.1
estimate
0.0
0.0
—
9
82
(3002256) Pathology report gross observation
19
126
1.59
0.98
1.5
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
37
1.94
0.95
1.6
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
39
483
0.73
0.88
3.1
4.2
ng/l
42.1
64.3
0.54
31
382
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
30
2.05
0.88
1.0
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
19
266
0.67
0.85
3.3
3.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
96
1040
0.73
0.84
27.4
16.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
32
1.91
0.83
1.2
1.4
—
—
—
0
0
(3013512) EKG study
27
352
0.71
0.83
4.5
4.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
48
1.71
0.80
2.1
1.9
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
25
0.00
0.80
0.0
3.2
—
37.7
—
0
6
(4094501)
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
27
0.00
0.78
0.0
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
34
1.80
0.77
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
17
237
0.68
0.75
1.5
1.8
pmol/l
402.5
412.3
0.07
17
200
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
25
2.04
0.73
1.0
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
29
366
0.73
0.72
2.1
4.1
mg/mmol
14.1
10.1
0.32
19
247
(3026008) Bacteria identified in Urine by Culture
36
289
1.34
0.71
2.2
2.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
26
1.96
0.71
1.2
2.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
35
283
1.32
0.66
1.8
1.8
mg/l
3.0
3.1
0.09
29
248
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
44
1.62
0.66
2.0
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
100
1063
0.77
0.61
37.6
19.9
mmol/l
137.3
139.5
6.60
95
1031
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
22
0.00
0.60
0.0
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
23
0.00
0.59
0.0
2.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
59
1.56
0.56
11.8
10.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
9
64
1.44
0.53
1.1
1.6
g/l
1.7
1.5
—
9
56
(3000494) Fungus identified in Specimen by Culture
18
137
1.36
0.50
1.2
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
29
348
0.79
0.49
1.8
3.3
mg/l
1776.8
70.9
0.49
20
239
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
50
1.42
0.46
1.0
2.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
17
132
1.33
0.43
9.9
8.0
%
97.3
95.8
1.45
17
127
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
68
621
1.19
0.42
3.8
3.1
u/l
52.0
54.3
0.10
62
579
(3011412) CD3 cells [#/volume] in Blood
0
15
0.00
0.41
0.0
2.4
—
0.9
—
0
5
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
19
0.00
0.39
0.0
3.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
69
1.33
0.38
3.0
2.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
70
753
0.85
0.37
3.5
4.1
mm/h
17.3
13.5
0.72
60
691
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
6
41
1.48
0.36
1.0
2.6
g/l
35.8
37.0
—
6
33
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
6
43
1.41
0.35
1.0
2.5
g/l
0.0
0.5
—
6
38
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
42
373
1.18
0.35
1.6
2.2
nmol/l
72.0
74.6
0.15
36
322
(3004588) Protein electrophoresis panel - Serum or Plasma
6
86
0.68
0.34
1.3
2.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
73
680
1.16
0.33
4.9
3.3
pmol/l
14.5
14.9
0.61
66
598
(3002385) Erythrocyte distribution width [Ratio]
84
794
1.16
0.30
38.3
20.9
%
14.7
13.9
2.58
79
773
(3022145) Colonoscopy Study observation
9
116
0.76
0.29
1.6
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
62
1.31
0.28
1.5
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
24
207
1.19
0.27
1.3
1.9
mg/l
1.4
1.5
0.01
18
164
(3019309) Folate [Moles/volume] in Red Blood Cells
26
227
1.18
0.26
1.6
1.7
nmol/l
1375.5
1196.2
0.29
19
178
(3011397) Hemoglobin [Presence] in Urine by Test strip
20
232
0.84
0.25
1.8
3.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
81
848
0.89
0.24
38.0
17.6
%
35.9
39.9
3.07
61
555
(4010399)
7
91
0.76
0.23
1.3
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
5
39
1.29
0.23
1.0
1.1
—
57.9
—
0
10
(40768443) Skin Pathology biopsy report
5
41
1.23
0.22
1.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
42
1.20
0.21
1.4
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
11
89
1.26
0.21
5.7
4.1
mmol/l
1.2
1.2
1.27
11
82
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
30.5
—
0
5
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
4.4
—
0
11
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
11
0.00
0.21
0.0
7.7
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
452.5
—
0
6
(4062490)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
249.4
—
0
5
(3038026) Centromere Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(4146454)
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
2.2
—
470.2
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.7
—
95.0
—
0
5
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.1
—
281.7
—
0
13
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
50
1.21
0.20
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
47
439
1.11
0.18
2.1
2.0
pmol/l
77.4
88.9
1.41
26
262
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
86
889
0.91
0.17
5.5
4.0
mu/l
3.1
2.0
1.59
80
782
(3028026) IgM [Mass/volume] in Serum or Plasma
8
72
1.12
0.16
1.5
1.6
g/l
1.0
1.1
—
8
66
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
46
481
0.93
0.10
2.4
2.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
54
1.12
0.09
1.5
2.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
55
1.10
0.09
1.3
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
65
1.08
0.08
1.3
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
78
1.03
0.07
5.4
4.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
85
1.06
0.07
6.7
3.9
—
—
—
0
0
(3000492) Spirometry study
9
87
1.04
0.07
1.3
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
40
386
1.05
0.06
2.7
2.5
ug/l
202.1
184.5
0.13
32
354
(3044889) 12 lead EKG panel
73
743
0.96
0.05
4.9
4.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
131
1.08
0.03
1.6
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
21
201
1.05
0.03
4.3
5.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
11
102
1.09
0.03
2.4
3.3
kpa
4.5
4.5
0.04
11
93
(3037467) Urinalysis macro (dipstick) panel - Urine
69
680
1.03
0.03
3.7
4.1
—
—
—
0
0
(3019225) pH of Specimen
11
114
0.96
0.00
5.6
4.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
95
1.06
0.00
1.4
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
11
115
0.95
0.00
1.3
1.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
1.2
—
0
5
(3028707) Methadone [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
0
5
0.00
0.00
0.0
4.4
—
8.2
—
0
5
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
13.7
—
0
5
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
158.4
—
0
5
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
4.8
—
212.6
—
0
5
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
248.8
—
0
6
(3012565) Volume of 24 hour Urine
0
7
0.00
0.00
0.0
1.9
—
2764.3
—
0
7
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
10
100
1.00
0.00
1.4
1.5
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.5
—
74.2
—
0
8
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
9
92
0.98
0.00
3.0
3.2
—
7.4
—
0
9
(3045716) Anion gap in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
10.5
—
0
6
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020891) Body temperature
5
54
0.92
0.00
2.2
4.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
7
0.00
0.00
0.0
5.9
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_HYPOPHARYNX – Malignant neoplasm of hypopharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).